SB 48

AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS

Vote Tally: General Law Committee (March 21, 2019)
CBIA opposed this bill, which passed 11- 5, with 3 legislators abstaining or absent.
Sen. (D-)
Rep. Tim Ackert (R-Coventry)
Sen. Dennis Bradley (D-Bridgeport)
Rep. Juan Candelaria (D-New Haven)
Rep. Vincent Candelora (R-North Branford)
Sen. John Fonfara (D-Hartford)
Rep. Bobby Gibson (D-Bloomfield)
Sen. John Kissel (R-Enfield)
Sen. Carlo Leone (D-Stamford)
Rep. Geoff Luxenberg (D-Manchester)
Sen. Douglas McCrory (D-Hartford)
Rep. Dave Rutigliano (R-Trumbull)
Sen. Kevin Witkos (R-Canton)

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.

CBIA IS FIGHTING TO MAKE CONNECTICUT A TOP STATE FOR BUSINESS, JOBS, AND ECONOMIC GROWTH. A BETTER BUSINESS CLIMATE MEANS A BRIGHTER FUTURE FOR EVERYONE.